# A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

> **NCT00424047** · PHASE3 · COMPLETED · sponsor: **Celgene** · enrollment: 351 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** CC-5013 plus dexamethasone
- **DRUG:** Dexamethasone plus Placebo

## Key facts

- **NCT ID:** NCT00424047
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01-01
- **Primary completion:** 2005-11-01
- **Final completion:** 2013-11-12
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424047, "A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00424047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*